^Referenzen

^{1. Parkin, J. & Cohen, B. An overview of the immune system. THE LANCET 1777–1789 (2001).}

^{2. Furman, D. et al. Chronic inflammation in the etiology of disease across the life span. Nat Med 25, 1822–1832 (2019).}

^{3. Gevaert, P. et al. The roles of eosinophils and interleukin-5 in the pathophysiology of chronic rhinosinusitis with nasal polyps. International Forum of Allergy and Rhinology vol. 12 1413–1423 Preprint at https://doi.org/10.1002/alr.22994 (2022).}

^{4. Janson, C. et al. Eosinophilic airway diseases: basic science, clinical manifestations and future challenges. European Clinical Respiratory Journal vol. 9 Preprint at https://doi.org/10.1080/20018525.2022.2040707 (2022).}

^{5. Nagase, H., Ueki, S. & Fujieda, S. The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis. Allergology International vol. 69 178–186 Preprint at https://doi.org/10.1016/j.alit.2020.02.002 (2020).}

^{6. Toppila-Salmi, S. et al. Multi-Disciplinary Expert Perspective on the Management of Type 2 Inflammation-Driven Severe CRSwNP: A Brief Overview of Pathophysiology and Recent Clinical Insights. J Asthma Allergy 17, 431–439 (2024).}

^{7. Gandhi, N. A. et al. Targeting key proximal drivers of type 2 inflammation in disease. Nature Reviews Drug Discovery vol. 15 35–50 Preprint at https://doi.org/10.1038/nrd4624 (2016).}

^{8. Wong, T. W., Doyle, A. D., Lee, J. J. & Jelinek, D. F. Eosinophils Regulate Peripheral B Cell Numbers in Both Mice and Humans. The Journal of Immunology 192, 3548–3558 (2014).}

^{9. Kuang, F. L., Makiya, M., Rampertaap, S., Holland-Thomas, N. & Klion, A. D. Exploring a relationship between B cells and eosinophils. Journal of Allergy and Clinical Immunology 143, AB289 (2019).}

^{10. Ramirez, G. A. et al. Eosinophils from Physiology to Disease: A Comprehensive Review. BioMed Research International vol. 2018 Preprint at https://doi.org/10.1155/2018/9095275 (2018).}

^{11. Gulati, G., Song, J., Florea, A. D. & Gong, J. Purpose and criteria for blood smear scan, blood smear examination, and blood smear review. Annals of Laboratory Medicine vol. 33 1–7 Preprint at https://doi.org/10.3343/alm.2013.33.1.1 (2013).}

^{12. Maspero, J. et al. Type 2 inflammation in asthma and other airway diseases. ERJ Open Research vol. 8 Preprint at https://doi.org/10.1183/23120541.00576-2021 (2022)}

^{13. Khan, A. H. et al. Prevalence and Severity Distribution of Type 2 Inflammation-Related Comorbidities Among Patients with Asthma, Chronic Rhinosinusitis with Nasal Polyps, and Atopic Dermatitis. Lung 201, 57–63 (2023).}

^{14. Hagemann, J. et al. EGPA: Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) as a special presentation of chronic rhinosinusitis with nasal polyps (CRSwNP). Allergologie vol. 47 124–132 Preprint at https://doi.org/10.5414/ALX02475E (2024).}

^{15. Damask, C. C. et al. Targeted Molecular Therapies in Allergy and Rhinology. Otolaryngology - Head and Neck Surgery (United States) 164, S1–S21 (2021).}

^{16. Laidlaw, T. M. & Buchheit, K. M. Biologics in chronic rhinosinusitis with nasal polyposis. Annals of Allergy, Asthma and Immunology vol. 124 326–332 Preprint at https://doi.org/10.1016/j.anai.2019.12.001 (2020).}

^{17. Klimek, L. & Spielhaupter, M. Praktische Allergologie. (Georg Thieme Verlag, 2010).}

^{18. Senna, G. et al. Multidisciplinary Management of Type 2 Inflammatory Diseases.}

^{19. Caminati, M., Senna, G., Maule, M., Di Sabatino, A. & Rossi, C. M. Diagnosis, management and therapeutic options for eosinophilic esophagitis. Curr Opin Allergy Clin Immunol 24, (2024).}

^{20. Palomares, O., Cisneros, C., Ortiz de Frutos, F. J., Villacampa, J. M. & Dávila, I. Multidisciplinary management of type 2 inflammation diseases using a screening tool. Frontiers in Allergy 5, (2024).}